Rothschild & Co Asset Management US’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-7,553
| Closed | -$5.03M | – | 273 |
|
2021
Q2 | $5.03M | Sell |
7,553
-8,993
| -54% | -$5.99M | 0.06% | 220 |
|
2021
Q1 | $14.4M | Sell |
16,546
-4,684
| -22% | -$4.06M | 0.18% | 160 |
|
2020
Q4 | $19.7M | Sell |
21,230
-2,792
| -12% | -$2.59M | 0.25% | 137 |
|
2020
Q3 | $24.7M | Sell |
24,022
-2,623
| -10% | -$2.7M | 0.44% | 86 |
|
2020
Q2 | $27M | Buy |
26,645
+21,364
| +405% | +$21.6M | 0.4% | 92 |
|
2020
Q1 | $4.59M | Sell |
5,281
-1,147
| -18% | -$996K | 0.07% | 254 |
|
2019
Q4 | $6.89M | Buy |
6,428
+633
| +11% | +$679K | 0.07% | 271 |
|
2019
Q3 | $5.36M | Sell |
5,795
-68
| -1% | -$62.9K | 0.06% | 280 |
|
2019
Q2 | $6.62M | Buy |
5,863
+352
| +6% | +$398K | 0.07% | 275 |
|
2019
Q1 | $7.49M | Sell |
5,511
-661
| -11% | -$898K | 0.08% | 271 |
|
2018
Q4 | $7.14M | Buy |
6,172
+348
| +6% | +$403K | 0.09% | 274 |
|
2018
Q3 | $8.85M | Sell |
5,824
-146
| -2% | -$222K | 0.09% | 277 |
|
2018
Q2 | $9.34M | Buy |
5,970
+54
| +0.9% | +$84.5K | 0.1% | 270 |
|
2018
Q1 | $6.83M | Sell |
5,916
-238
| -4% | -$275K | 0.08% | 274 |
|
2017
Q4 | $7.29M | Sell |
6,154
-778
| -11% | -$922K | 0.08% | 268 |
|
2017
Q3 | $9.32M | Sell |
6,932
-309
| -4% | -$416K | 0.1% | 259 |
|
2017
Q2 | $5.85M | Sell |
7,241
-199
| -3% | -$161K | 0.07% | 277 |
|
2017
Q1 | $4.59M | Buy |
7,440
+38
| +0.5% | +$23.4K | 0.05% | 281 |
|
2016
Q4 | $3.96M | Buy |
7,402
+2,128
| +40% | +$1.14M | 0.05% | 297 |
|
2016
Q3 | $2.73M | Buy |
5,274
+227
| +4% | +$117K | 0.05% | 296 |
|
2016
Q2 | $2.07M | Buy |
5,047
+444
| +10% | +$182K | 0.04% | 319 |
|
2016
Q1 | $2.45M | Buy |
4,603
+169
| +4% | +$90K | 0.05% | 290 |
|
2015
Q4 | $3.38M | Buy |
4,434
+1,731
| +64% | +$1.32M | 0.06% | 295 |
|
2015
Q3 | $1.48M | Buy |
+2,703
| New | +$1.48M | 0.03% | 316 |
|